Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Barbara Ziółkowska

Maria Sklodowska-Curie National Research Institute of Oncology

Poland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

20%

Pharmacotherapy

30%

Adjuvant Therapy

20%

Oncology

20%

Immunosenescence

20%

Graft-versus-host Disease

20%

Antibody Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles5

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

Article Link

Year:

2021

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

Article Link

Year:

2021

First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland.

Article Link

Year:

2020

Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Article Link

Year:

2020

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

Article Link

Year:

2020

Collaborators2

Grazyna Kaminska-Winciorek

Associate Prof. M.D.Ph.D., scientific position; Head of the Skin Cancer and Melanoma Team in MSCNRIO, Gliwice Branch; medical consultant

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

How do I reach out?

Meet Kite AI